Side-by-side comparison of AI visibility scores, market position, and capabilities
SF/Chile YC W21 browser-based collaborative 3D design platform at $32M total ($16M Third Point/Gradient Series A Jun 2024) and $55M valuation; no-code 3D for web/app/game competing with Rive and Blender for interactive 3D content creation.
Spline is a Santiago, Chile-founded (now San Francisco-based) collaborative web 3D design platform — backed by Y Combinator (W21) with $32 million in total funding including a $16 million Series A in June 2024 led by Third Point Ventures with participation from First Round Capital, Gradient Ventures (Google's AI fund), and YC — providing designers and developers with a browser-based 3D design tool for creating interactive 3D experiences, game elements, product configurators, and motion graphics without writing three.js or WebGL code. Founded in 2020 and reaching a $55 million valuation in July 2023, Spline serves the growing community of web designers who want to incorporate 3D interactive elements (spinning product models, 3D landing page heroes, animated 3D icons) into websites and apps through a no-code visual editor with real-time collaboration.
Open-source browser-based API testing platform with 500K+ developers; $3M seed from OSS Capital competing with Postman as a lightweight, self-hostable alternative for REST and GraphQL testing.
Hoppscotch is an open-source API development and testing platform — providing a web-based, lightweight alternative to Postman and Insomnia for building, testing, and documenting REST, GraphQL, WebSocket, and gRPC APIs. Founded in 2019 by Liyas Thomas and Andrew Bastin in Kochi, India, Hoppscotch has grown to 500,000+ developers globally using the platform, raised $3 million in seed funding led by OSS Capital with participation from Automattic (WordPress.com parent), and offers a free open-source version alongside Hoppscotch Pro cloud with team collaboration and private workspaces.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.